 Aims of the study : 1 To determine whether the presence of the V158 allele of Fc gammaRIIIA gene is associated with a better outcome of Immune Thrombocytopenia ITP in adults and especially with a higher response-rate to rituximab. 2 To analyze the impact of therapy and especially rituximab on some B and T cells autoreactive subsets in the peripheral blood. 